Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal Carcinoma
Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
The aim of this study is to define whether combination of induction chemotherapy and PD-1
inhibitor (Toripalimab) followed by radiotherapy improve progression-free survival, for
patients with unresectable laryngeal/hypopharyngeal carcinoma.